Biotest Pharmaceuticals Corporation
5800 Park of Commerce Boulevard N.W.
Boca Raton
Florida
33487
United States
Tel: 561-989-5800
Fax: 561-989-5874
Website: http://www.biotestpharmadev.com/
Email: hr@biotestpharma.com
About Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals researches and manufactures bio-therapeutic products with a specialization in immunology and hematology. Biotest Pharmaceuticals is a leader in the collection of source plasma and is currently involved in the development of plasma protein products in the field of Primary Immune Deficiency (PID) and various hyper-immune (IG) products which are antibody specific to high titer for treatment of modality.
Established in 2007, Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. Biotest Pharmaceuticals employs more than 900 employees in the US. Biotest Pharmaceuticals is a subsidiary of Biotest AG, a German-based global provider of plasma protein therapies that employs approximately 1,800 people worldwide.
33 articles about Biotest Pharmaceuticals Corporation
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
-
Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio
9/24/2018
Grifols is pleased to announce the opening of its newest Biotest Pharmaceuticals Corporation plasma donor center located at 1616 East Wooster Street, Bowling Green, Ohio.
-
Biotest Pharmaceuticals Corporation Announces Acquisition of Biotest US Corporation by Grifols Shared Services North America, Inc.
8/1/2018
Biotest Pharmaceuticals Corporation (BPC), a wholly owned subsidiary of Biotest US Corporation ("Biotest USA"), and a leader in the collection of Source Plasma, is pleased to announce that Grifols Shared Services North America, Inc., a wholly owned subsidiary of Grifols, S.A. has completed its acquisition of Biotest USA for $286 Million in cash.
-
Biotest Pharma Announces The Relocation Of Its Plasma Collection Facility To Hollywood, Florida
8/1/2017
-
ADMA Biologics, Inc. Completes Acquisition Of Biotest Pharma’s Therapy Business Unit Assets
6/7/2017
-
ADMA Biologics, Inc. Stockholders Vote To Approve Acquisition Of Certain Assets From Biotest Pharma
5/30/2017
-
Beijing's Creat Offers $1.3 Billion For German Blood Plasma Company Biotest Pharma
3/31/2017
-
Biotest Pharma Announces The Relocation Of Its Plasma Collection Facility In Gainesville, Florida
1/27/2017
-
Biotest Pharma Announces The Opening Of Its Newest Plasma Collection Facility In Kearney, Nebraska
11/30/2016
-
Biotest Pharma Announces The Opening Of Its Newest Plasma Collection Facility In Vermillion, South Dakota
9/27/2016
-
Biotest Pharma Announces The Opening Of Its Newest Plasma Collection Facility In Clemson, South Carolina
7/26/2016
-
Biotest Pharma Announces The Opening Of Its Newest Plasma Collection Facility In Brookings, South Dakota
5/23/2016
-
Biotest Pharma Announces The Appointment Of Kedrion Biopharma Inc. As The Exclusive Distributor Of Its IGIV Product, Bivigam In The US
1/19/2016
-
Biotest Pharma Announces The Relocation Of Its Plasma Collection Facility In Youngstown, Ohio
6/19/2015
-
Biotest Pharma Will Hire 50 As Newest Arkansas Plasma Site Opens
4/3/2015
-
Biotest Pharma Announces The Relocation Of Its Plasma Collection Facility In San Antonio, Texas
4/2/2015
-
Biotest Pharmaceuticals Announces The Opening Of Its Newest Plasma Collection Facility In Conway, Arkansas
3/31/2015
-
Biotest Pharmaceuticals Opens Second Jacksonville, North Carolina Plasma Center
2/9/2015
-
Biotest Pharmaceuticals Opens New Plasma Center In Royal Palm Beach, Florida
5/21/2014